BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31254926)

  • 1. Mammalian synthetic biology by CRISPRs engineering and applications.
    Katayama K; Mitsunobu H; Nishida K
    Curr Opin Chem Biol; 2019 Oct; 52():79-84. PubMed ID: 31254926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian Synthetic Biology: Engineering Biological Systems.
    Black JB; Perez-Pinera P; Gersbach CA
    Annu Rev Biomed Eng; 2017 Jun; 19():249-277. PubMed ID: 28633563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in genetic engineering tools based on synthetic biology.
    Ren J; Lee J; Na D
    J Microbiol; 2020 Jan; 58(1):1-10. PubMed ID: 31898252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
    Singh DD; Hawkins RD; Lahesmaa R; Tripathi SK
    Semin Cell Dev Biol; 2019 Dec; 96():32-43. PubMed ID: 31112800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB; Moses C; Arooj M; Blancafort P
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Mediated Epigenome Editing.
    Enríquez P
    Yale J Biol Med; 2016 Dec; 89(4):471-486. PubMed ID: 28018139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of genome engineering in medical synthetic biology].
    Wang F; Zhao D; Qi LS
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):422-435. PubMed ID: 28941341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR: gene editing is just the beginning.
    Ledford H
    Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity and specificity of TRV-mediated gene editing in plants.
    Ali Z; Abul-Faraj A; Piatek M; Mahfouz MM
    Plant Signal Behav; 2015; 10(10):e1044191. PubMed ID: 26039254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Synthetic Gene Circuits in Living Cells with CRISPR Technology.
    Jusiak B; Cleto S; Perez-Piñera P; Lu TK
    Trends Biotechnol; 2016 Jul; 34(7):535-547. PubMed ID: 26809780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR base editors: genome editing without double-stranded breaks.
    Eid A; Alshareef S; Mahfouz MM
    Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental history and application of CRISPR in human disease.
    Liang P; Zhang X; Chen Y; Huang J
    J Gene Med; 2017 Jun; 19(6-7):. PubMed ID: 28623876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.
    Khan FA; Pandupuspitasari NS; Chun-Jie H; Ao Z; Jamal M; Zohaib A; Khan FA; Hakim MR; ShuJun Z
    Oncotarget; 2016 Aug; 7(32):52541-52552. PubMed ID: 27250031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptive non-disruptive applications of CRISPR/Cas9.
    Schmid-Burgk JL
    Curr Opin Biotechnol; 2017 Dec; 48():203-209. PubMed ID: 28633080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.